Earlier this year the FDA approved the PureGraft™ system, manufactured by Cytori Therapeutics, Inc. PureGraft™ is the first technology from Cytori to be cleared for U.S. sales. The technology is used during soft tissue augmentation procedures that require fat grafting, such as the Brazilian butt lift.
The PureGraft™ system expedites the lipotransfer process by purifying a patient’s own fat tissue for re-injection in approximately 15 minutes. This makes operating more efficient, decreases surgery time, processes larger volumes of tissue and decreases the risk of anesthesia-related complications.
The technology became available early in 2010 and was approved in Europe at the end of last month.
Fat grafting has seen a dramatic increase in demand in the recent past. According to the 2009 American Society for Aesthetic Plastic Surgery statistics, 42,541 patients underwent fat grafting procedures in the U.S. last year.
To Your Health & Beauty,
Kent V. Hasen, M.D.